Search

Hikma Pharmaceuticals PLC

Chiusa

SettoreSettore sanitario

1,616 1.89

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1573

Massimo

1606

Metriche Chiave

By Trading Economics

Entrata

56M

221M

Vendite

15M

1.7B

P/E

Media del settore

12.212

55.725

Rendimento da dividendi

5.34

Margine di Profitto

12.905

Dipendenti

9,500

EBITDA

67M

478M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+20.11% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

5.34%

2.25%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

50M

3.3B

Apertura precedente

1614.11

Chiusura precedente

1616

Notizie sul Sentiment di mercato

By Acuity

29%

71%

54 / 339 Classifica in Healthcare

Hikma Pharmaceuticals PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

23 set 2026, 23:31 UTC

News
Social Media

Amazon.com Inc. is declining in after-market trading amid rising Treasury yields and geopolitical tensions, contributing to broader market downturns.

23 set 2026, 23:31 UTC

News

BWX Technologies Inc. received a BBB investment grade credit rating from Fitch Ratings, boosting after-market trading modestly higher.

23 set 2026, 23:31 UTC

Correlated Moves
News
Event

H.B. Fuller reported Q3 2026 net revenue of $938 million and adjusted EPS of $1.52, exceeding estimates, and traded higher in after-market hours.

23 set 2026, 23:26 UTC

Social Media
News

Robinhood Markets Inc. is trading slightly higher in after-market hours, bolstered by 13 revenue streams each generating over $100 million annually and positive growth forecasts.

23 set 2026, 23:25 UTC

News

Kraft Heinz Co is trading higher in after-market hours following RBC Capital Markets' "Outperform" rating and $32 price target, projecting 0.9% revenue growth by 2027.

23 set 2026, 23:21 UTC

News
Social Media

Meta Platforms Inc. is trading lower after-hours despite the launch of its Muse AI personal agent, which has garnered significant social media attention.

23 set 2026, 23:20 UTC

News

Goldman Sachs is selling Applied Systems, valued at up to $10 billion, as its stock moves higher in after-market trading amid active investment banking.

23 set 2026, 23:20 UTC

News

DoorDash Inc plans to pay $131.5 million to settle worker underpayment allegations, with its stock trading lower in after-market hours following the announcement.

23 set 2026, 23:16 UTC

News

Ethereum is trading lower, diverging from recent gains, amid rising U.S. crude oil inventories and strong economic data indicating robust private sector growth.

23 set 2026, 23:15 UTC

Social Media
News

Gossamer Bio Inc has submitted a New Drug Application for seralutinib targeting pulmonary arterial hypertension, with shares advancing in after-market trading.

23 set 2026, 23:15 UTC

News

Cooper Companies Inc's stock declines in after-market trading following a $30 million revenue miss in Q3, despite announcing a new global innovation hub in England.

23 set 2026, 23:15 UTC

News

AutoNation Inc announced a $1 million investment in cancer research grants, with its stock advancing modestly in after-market trading following the announcement.

23 set 2026, 23:11 UTC

Correlated Moves
News

The USD/SEK is advancing modestly as the U.S. dollar strengthens amid signals of potential Federal Reserve rate hikes to combat inflation.

23 set 2026, 23:06 UTC

News

UPS shares are slightly higher in after-market trading amid scrutiny over the diversion of sensitive F-35 parts to Hong Kong by the Chinese government.

23 set 2026, 23:06 UTC

Correlated Moves
News

Lockheed Martin's stock has gained in after-market hours following reports of the Chinese government seizing sensitive F-35 parts during shipment from Australia to the U.S.

23 set 2026, 23:06 UTC

Correlated Moves
News

Wells Fargo shares are modestly higher in after-market trading following the announcement of Chief Risk Officer Derek Flowers' upcoming retirement in mid-January.

23 set 2026, 23:06 UTC

Social Media
News

McDonald's is exploring menu growth opportunities for households using GLP-1 medications, with plans to reintroduce salads and grilled chicken items, gaining in after-market trading.

23 set 2026, 23:05 UTC

News

Lennar Corp. announced a quarterly dividend of $0.50 per share and reported increased stake from Berkshire Hathaway, with shares trading higher in after-market hours.

23 set 2026, 23:05 UTC

News

Altria Group Inc. is experiencing a decline in after-market trading amid potential regulatory changes for smoke-free nicotine products, raising concerns among public health advocates.

23 set 2026, 23:05 UTC

News

PepsiCo announced a significant order for 10k electric trucks through the ZET SCALE alliance, while its stock traded roughly flat in after-market hours.

23 set 2026, 23:05 UTC

News

Verizon grants $1 million to Liberty Science Center for AI initiative.

23 set 2026, 23:05 UTC

News

The USD/NOK is advancing modestly as U.S. crude oil inventories rose by 2.969 million barrels, raising supply concerns affecting the Norwegian krone.

23 set 2026, 23:05 UTC

News

General Mills Inc reports Q1 fiscal 2027 results with improved dollar sales and strong e-commerce growth, trading slightly higher in after-market hours.

23 set 2026, 23:01 UTC

News

Regenxbio Inc. has settled patent litigation with Sarepta Therapeutics, receiving $39 million, leading to a rise in after-market trading.

23 set 2026, 23:01 UTC

News

TransUnion shares are trading lower after CFO Todd Cello announced his planned departure at the end of 2026, despite reaffirmed financial guidance.

23 set 2026, 23:01 UTC

Correlated Moves
News

JPMorgan Chase & Co is involved in the sale of Applied Systems, valued at up to $10 billion, and is modestly higher in after-market trading.

23 set 2026, 23:01 UTC

News

AbbVie Inc. is down slightly in after-market trading, pulling back from an earlier session high, with a "Sell" rating and a price target of $191.

23 set 2026, 23:01 UTC

News
Social Media

MGM Resorts International's stock is sharply lower after Barry Diller withdrew his $18 billion acquisition bid, reaffirming the company's standalone commitment.

23 set 2026, 23:01 UTC

News

Arcturus Therapeutics announced positive interim Phase 2 results for ARCT-810 and unveiled its LUNAR 2.0 platform, yet the stock is trading lower in after-market hours.

23 set 2026, 23:01 UTC

News

The USD/THB is advancing, reaching its highest cumulative return amid strong U.S. private sector growth, with the S&P Global Composite PMI rising to 58.4.

Confronto tra pari

Modifica del prezzo

Hikma Pharmaceuticals PLC Previsione

Obiettivo di Prezzo

By TipRanks

20.11% in crescita

Previsioni per 12 mesi

Media 1,929 GBX  20.11%

Alto 2,100 GBX

Basso 1,700 GBX

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Hikma Pharmaceuticals PLC - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

5 ratings

4

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

54 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.